The tumor microenvironment at different stages of hepatic metastasis

Cancer Metastasis - Biology and Treatment

Volumn 16, Issue 1, 2011, Pages 43-87

  Vidal Vanaclocha, Fernando ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Hepatocytes; Liver sinusoidal cells; Metastasis related genes; Tumor microenvironment; Tumor stroma

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; MANNOSE RECEPTOR; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL ADHESION; ENDOCYTOSIS; GENE EXPRESSION; HEPATITIS; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LIVER; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER METASTASIS; LIVER REGENERATION; LYMPHOCYTIC INFILTRATION; MICROCIRCULATION; MICROMETASTASIS; MICROVASCULAR ENDOTHELIAL CELL; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGENERATION; STELLATE CELL; STROMA CELL; TUMOR MICROENVIRONMENT;

EID: 84870542319     PISSN: 15682102     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-0292-9_3     Document Type: Article

References (124)

1. Weiss L (1994) Inefficiency of metastasis from colorectal carcinomas. Relationship to local therapy for hepatic metastasis. Cancer Treat Res 69:1-11
2. Chambers AF, Naumov GN, Vantyghem SA, Tuck AB (2000) Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res 2:400-407
3. Vidal-Vanaclocha F (2008) The prometastatic microenvironment of the liver. Cancer Microenviron 1:113-129
4. Weiss L (1992) Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis. Cancer Met Rev 11:227-235
5. Barberá-Guillem E, Smith I, Weiss L (1993) Cancer-cell traffic in the liver. II. Arrest, transit and death of B16F10 and M5076 cells in the sinusoids. Int J Cancer 53:298-301
6. Jessup J, Battle P, Waller H et al (1999) Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells. Cancer Res 59:1825-1829
7. Wang H, McIntosh A, Hasinoff B et al (2000) B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res 60:5862-5869
8. Anasagasti MJ, Alvarez A, Avivi C et al (1996) Interleukin-1-mediated H2O2 production by hepatic sinusoidal endothelium in response to B16 melanoma cell adhesion. J Cell Physiol 167:314-323
9. Roos E, Dingemans KP, Van de Pavert IV et al (1978) Mammary-carcinoma cells in mouse liver: infiltration of liver tissue and interaction with Kupffer cells. Br J Cancer 38:88-99
10. Kan Z, Ivancev K, Lunderquist A et al (1995) In vivo microscopy of hepatic metastases: dynamic observation of tumor cell invasion and interaction with Kupffer cells. Hepatology 21:487-494
11. Bayón LG, Izquierdo MA, Sirovich I et al (1996) Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology 23:1224-1231
12. Timmers M, Vekemans K, Vermijlen D et al (2004) Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 112:793-802
13. Bouwens L, Jacobs R, Remels L (1988) Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma. Cancer Immunol Immunother 27:137-141
14. Gardner CR, Wasserman AJ, Laskin DL (1991) Liver macrophage mediated cytotoxicity toward mastocytoma cells involves phagocytosis of tumor targets. Hepatology 14:318-324
15. Vermijlen D, Luo D, Robaye B et al (1999) Pit cells (Hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway. Hepatology 29:51-56
16. Vekemans K, Timmers M, Vermijlen D et al (2003) CC531 colon carcinoma cells induce apoptosis in rat hepatic endothelial cells by the Fas/FasL-mediated pathway. Liver Int 23:283-293
17. Vidal-Vanaclocha F, Alonso A, Barberá-Guillem E (1990) Functional variations of liver tissue during the hepatic colonization by metastatic tumor cells. Virchows Arch A Pathol Anat 416:189-195
18. Arteta B, Lasuen N, Lopategi A et al (2010) Colon carcinoma cell interaction with liver sinusoidal endothelium inhibits organ-specific anti-tumor immunity via IL-1-induced mannose receptor. Hepatology 51:2172-2182
19. Mendoza L, Carrascal T, de Luca M et al (2001) Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from IL-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in murine liver. Hepatology 34:298-310
20. Vidal-Vanaclocha F, Fantuzzi G, Mendoza L et al (2000) IL-18 regulates IL-1 beta-dependent hepatic melanoma metastasis via vascular adhesion molecule-1. Proc Natl Acad Sci USA 97:734-739
21. Khatib AM, Auguste P, Fallavollita L et al (2005) Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol 167:749-759
22. Anasagasti MJ, Alvarez A, Martin JJ et al (1997) Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis in mice. Hepatology 25:840-846
23. Vidal-Vanaclocha F, Amézaga C, Asumendi A et al (1994) Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 54:2667-2672
24. Carrascal T, Mendoza L, Vacarcel M et al (2003) Interleukin-18 binding protein reduces B16 melanoma hepatic metastasis by neutralizing the adhesiveness and growth factors of sinusoidal endothelial cell. Cancer Res 63:491-497
25. Vidal-Vanaclocha F, Alvarez A, Asumendi A et al (1996) Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J Natl Cancer Inst 88:198-205
26. Zubia A, Mendoza L, Vivanco S et al (2005) Application of stereocontrolled stepwise [3+2]. Cycloadditions to the preparation of inhibitors of alpha(4)beta(1)-integrin-mediated hepatic melanoma metastasis. Angew Chem Int Ed Engl 44:2903-2907
27. Moller B, Paulukat J, Nold M et al (2003) Interferon-gamma induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes. Rheumatology (Oxford) 42:442-445
28. Dinarello, CA, Novick D, Puren AJ et al (1998) Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukocyte Biol 63:658-666
29. Vidal-Vanaclocha F, Mendoza L, Telleria N et al (2006) Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. Cancer Metastasis Rev 25:417-434
30. Wang N, Thuraisingam T, Fallavollita L et al (2006) The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response. Cancer Res 66:3062-3070
31. Auguste P, Fallavollita L, Wang N et al (2007) The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol 170: 1781-1792
32. Stahl PD, Ezekowitz RA (1998) The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 10:50-55
33. Knolle PA, Gerken G (2000) Local control of the immune response in the liver. Immunol Rev 174:21-34
34. Fujisaki T, Tanaka Y, Fujii K et al (1999) CD44 stimulation induces integrin mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res 59:4427-4434
35. Valcárcel M, Arteta B, Jaureguibeitia A et al (2008) Three-dimensional growth as multicellular spheroid activates the proangiogenic phenotype of colorectal carcinoma cells via LFA-1-dependent VEGF: implications on hepatic micrometastasis. J Transl Med 9:57-69
36. Kamekazi S, Kurozawa Y, Iwai N et al (2005) Serum levels of soluble ICAM-1 and VCAM-1 predict pre-clinical cancer. Eur J Cancer 41:2355-2359
37. Kooy AJ, Tank B, Vuzevski VD et al (1998) Expression of interferon-gamma receptors and interferon-gamma-induced up-regulation of intercellular adhesion molecule-1 in basal cell carcinoma; decreased expression of IFN-gamma R and shedding of ICAM-1 as a means to escape immune surveillance. J Pathol 184:169-176
38. Gho YS, Kleinman HK, Sosne G (1999) Angiogenic activity of human soluble intercellular adhesion-1. Cancer Res 59:5128-5132
39. Roossien FF, de Rijk D, Bikker A et al (1989) Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1 deficient mutants. J Cell Biol 108: 1979-1985
40. Wang HS, Hung Y, Su CH et al (2005) CD44 cross-linking induces-integrin mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alphaL beta2) and VLA-4 (alpha4 beta 1). Exp Cell Res 304:116-126
41. Cohen S, Haimovich J, Hollander N (2003) Anti-idiotype x anti-LFA-1 bispecific antibodies inhibit metastasis of B cell lymphoma. J Immunol 170:2695-2701
42. Aoudjit F, Potoworowski EF, Springer TA et al (1998) Protection from lymphoma cell metastasis in ICAM-1 mutant mice: a posthoming event. J Immunol 161:2333-2338
43. Jessup JM, Laguinge L, Lin S et al (2004) Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cells. Int J Cancer 111:332-337
44. Jessup JM, Samara R, Battle P et al (2004) Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway. Clin Exp Metastasis 21:709-717
45. Luo D, Vermijlen D, Kuppen PJ et al (2002) MHC class I expression protects rat colon carcinoma cells from hepatic natural killer cell-mediated apoptosis and cytolysis, by blocking the perforin/granzyme pathway. J Comp Hepatol 1:2
46. Anasagasti MJ, Martin JJ, Mendoza L et al (1998) Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature. Hepatology 27: 1249-1256
47. Estrela JM, Ortega A, Obrador E (2006) Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43:143-181
48. Olaso E, Santisteban A, Bidaurrazaga J et al (1997) Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 26: 634-642
49. Olaso E, Salado C, Egilegor E et al (2003) Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37:674-685
50. Deleve LD, Wang X, Guo Y (2008) Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology 48:920-930
51. Gressner AM, Bachem MG (1995) Molecular mechanisms of liver fibrogenesis - a homage to the role of activated fat-storing cells. Digestion 56:335-346
52. Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655-1669
53. Barberá-Guillem E, Alonso-Varona A, Vidal-Vanaclocha F (1989) Selective implantation and growth in rats and mice of experimental liver metastasis in acinar zone one. Cancer Res 49:4003-4010
54. Kaplan RN, Rafii S, Lyden D (2006) Preparing the "soil": the premetastatic niche. Cancer Res 66:11089-11093
55. Jungermann K (1995) Zonation of metabolism and gene expression in liver. Histochem Cell Biol 103:81-91
56. Jungermann K, Kietzmann T (2000) Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31:255-260
57. Kemperman H, Wijnands Y, Meijne AM et al (1994) TA3/St, but not TA3/Ha, mammary carcinoma cell adhesion to hepatocytes is mediated by alpha 5 beta 1 interacting with surface-associated fibronectin. Cell Adhes Commun 2:45-58
58. Shimizu S, Yamada N, Sawada T et al (2000) Ultrastructure of early phase hepatic metastasis of human colon carcinoma cells with special reference to desmosomal junctions with hepatocytes. Pathol Int 50:953-959
59. Shimizu S, Yamada N, Sawada T et al (2000) In vivo and in vitro interactions between human colon carcinoma cells and hepatic stellate cells. Jpn J Cancer Res 91:1285-1295
60. Solaun MS, Mendoza L, de Luca M et al (2002) Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium. Hepatology 35:1104-1116
61. Olaso E, Arteta B, Salado C (2006) Proangiogenic implications of hepatic stellate cell transdifferentiation into myofibroblasts induced by tumor microenvironment. In: Chaponnier C (ed) Tissue repair, contraction and the myofibroblast. Landes Publication, Austin
62. Mueller L, Goumas FA, Affeldt M et al (2007) Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am J Pathol 171:1608-1618
63. Basaldua F, Vidal-Vanaclocha F (2008) Nerve growth factor expression by hepatic parenchymal and non-parenchymal cells during metastatic colorectal development in human and murine liver. Proceedings of the 14th International Symposium on Cells of the Hepatic Sinusoid (ISCHS), Tromso (Norway)
64. Basaldua F, Lopategi A, Arteta B et al (2008) Tumor-induced liver nerve growth factor (NGF): a new target for stromal cell inhibition during metastatic colorectal carcinoma growth. Eur J Cancer 12:55
65. Shaheen RM, Tseng W, Davis DW et al (2001) Tyrosine kinase inhibition of multiple angiogenic growth factors receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanism. Cancer Res 61: 1464-1468
66. Reinmuth N, Liu W, Ahmad SA et al (2003) AlphaVbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Res 63:2079-2087
67. Wang YQ, Ikeda K, Ikebe T et al (2000) Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats. Hepatology 32:980-989
68. Kinoshita S, Hirai R, Yamano T et al (2004) Inhibitor TNP-470 can suppress hepatocellular carcinoma growth without retarding liver regeneration after partial hepatectomy. Surg Today 34:40-46
69. Godichaud S, Krisa S, Couronne et al (2000) Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology 31:922-931
70. Fenwick SW, Toogood GJ, Lodge JP et al (2003) The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology 125:716-729
71. Wei D, Wang L, He Y et al (2004) Celecoxib inhibits VEGF expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res 64:2030-2038
72. Yang ZF, Poon RT, To J et al (2004) The potential role of HIF1-alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma. Cancer Res 64:5496-5503
73. Yu C, Rahmani M, Almenara J et al (2004) Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process. Oncogene 23:1364-1376
74. Snader KM, Vishnuvajjala BR, Sausville EA et al (2002) 17-Dimethylaminoethylamino-17-desmethoxygeldanamycin (17-DMAG), a potent Hsp90 inhibitor with improved pharmaceutical and antitumor properties. In: 1st International symposium on signal transduction modulators in cancer therapy, Amsterdam
75. Kishibe K, Yamada Y, Ogawa K (2002) Production of nerve growth factor by mouse hepatocellular carcinoma cells and expression of TrkA in tumor-associated arteries in mice. Gastroenterology 122:1978-1986
76. Rasi G, Serafino A, Bellis L et al (2007) Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol 13:4986-4995
77. Paku S, Lapis K (1993) Morphological aspects of angiogenesis in experimental liver metastases. Am J Pathol 143:926-936
78. Vermeulen PB, Colpaert C, Salgado R et al (2001) Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol 195:336-342
79. Clement B, Musso O, Lietard J et al (1999) Homeostatic control of angiogenesis: a newly identified function of the liver? Hepatology 29:621-623
80. Maeda K, Nishiguchi Y, Kang SM et al (2001) Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer. Oncol Rep 8:763-766
81. O'Reilly MS, Boehm T, Shing Y et al (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285
82. Musso O, Theret N, Heljasvaara R et al (2001) Tumor hepatocytes and basement membrane-producing cells specifically express two different forms of the endostatin precursor, collagen XVIII, in human liver cancers. Hepatology 4:868-876
83. Yoon SS, Eto H, Lin C-M et al (1999) Mouse endostatin inhibits the formation of lung and liver metastases. Cancer Res 59:6251-6256
84. Mendoza L, Valcárcel M, Carrascal T et al (2004) Inhibition of cytokine-induced microvascular arrest of tumor cells by recombinant endostatin prevents experimental hepatic melanoma metastasis. Cancer Res 64:304-310
85. Feldman AL, Tamarkin L, Paciotti GF et al (2000) Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Clin Cancer Res 6:4628-4634
86. Kuroi K, Tanaka C, Toi M (2001) Circulating levels of endostatin in cancer patients. Oncol Rep 8:405-409
87. Iughetti P, Suzuki O, Godoi PH et al (2001) A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Cancer Res 61:7375-7378
88. Kim YM, Jang JW, Lee OH et al (2000) Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res 60:5410-5413
89. Winnock M, Garcia-Barcina M, Huet S et al (1993) Functional characterization of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology 105: 1152-1158
90. Kobayashi N, Hiraoka N, Yamagami W et al (2007) FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 13:902-911
91. Ooi LP, Crawford DH, Gotley DC et al (1997) Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol 26: 798-807
92. Stoeltzing O, Liu W, Reinmuth N et al (2003) Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis. Ann Surg Oncol 10:722-733
93. Bauer TW, Fan F, Liu W et al (2007) Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice. Ann Surg Oncol 14:2838-2846
94. Yamasaki M, Takemasa I, Komori T et al (2007) The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 30:129-138
95. Murthy SM, Goldschmidt RA, Rao LN et al (1989) The influence of surgical trauma on experimental metastasis. Cancer 64:2035-2044
96. Murthy MS, Scanlon EF, Jelachich ML et al (1995) Growth and metastasis of human breast cancers in athymic nude mice. Clin Exp Metastasis 13:3-15
97. Bogden AE, Moreau J-P, Eden PA (1997) Proliferative response of human animal tumors to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer 75: 1021-1027
98. Hofer SO, Shrayer D, Reichner JS et al (1998) Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg 133:383-389
99. Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77:1254-1262
100. Jaeck D, Bachellier P, Guiguet M et al (1997) Long-term survival following resection of colorectal hepatic metastases. Br J Surg 84:977-980
101. Makuuchi M, Le Thai B, Takayasu K et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107:521-527
102. Elias D, Roche A, Vavasseur D et al (1992) Induction of hypertrophy of a small left hepatic lobe by preoperative right portal embolization, preceding extended right hepatectomy. Ann Chir 46:404-410
103. Azoulay D, Castaing D, Smail A et al (2000) Resection of non resectable liver metastases from colorectal cancer after percutaneous PVE. Ann Surg 231:480-486
104. Liu H, Zhu S (2009) Present status and future perspectives of preoperative portal vein embolization. Am J Surgery 197:686-690
105. Elias D, de Baere T, Roche A et al (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86:784-788
106. Higgins GM, Anderson RM (1931) Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12:186-202
107. Ichihashi H, Mabuchi H, Suenaga M et al (1984) Liver regeneration and tumor growth in the rat after partial hepatectomy. Jpn J Surg 14:510-514
108. Morimoto H, Nio Y, Imai S et al (1992) Hepatectomy accelerates the growth of transplanted liver tumor in mice. Cancer Detec Prev 16:137-147
109. Panis Y, Ribeiro J, Chretien Y et al (1992) Dormant liver metastases: an experimental study. Br J Surg 79:221-223
110. Gutman M, Singh RK, Price JE et al (1994) Accelerated growth of human colon cancer cells in nude mice undergoing liver regeneration. Inv Metastasis 14:362-371
111. Asaga T, Suzuki K, Umeda M et al (1991) The enhancement of tumor growth after partial hepatectomy and the effect of sera obtained from hepatectomized rats on tumor cell growth. Jpn J Surg 21:669-675
112. Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267-272
113. Takahara T, Xue F, Mazzone M et al (2008) Metron factor-1 prevents liver injury without promoting tumor growth and metastasis. Hepatology 47:2010-2025
114. Gervaz P, Pak-art R, Nivatvongs S et al (2003) Colorectal adenocarcinoma in cirrhotic patients. J Am Coll Surg 196:874-879
115. Melato M, Laurino L, Mucli E et al (1989) Relationship between cirrhosis, liver cancer, and hepatic metastases. An autopsy study. Cancer 64:455-459
116. Pereira-Lima JE, Lichtenfels E, Barbosa FS et al (2003) Prevalence study of metastases in cirrhotic livers. Hepatogastroenterology 50:1490-1495
117. Seymour K, Charnley RM (1999) Evidence that metastasis is less common in cirrhotic than normal liver: a systematic review of post-mortem case-control studies. Br J Surg 86: 1237-1242
118. Song E, Chen J, Ouyang N et al (2001) Kupffer cells of cirrhotic rat livers sensitize colon cancer cells to Fas-mediated apoptosis. Br J Cancer 84:1265-1271
119. Uetsuji S, Yamamura M, Yamamichi K et al (1992) Absence of colorectal cancer metastasis to the cirrhotic liver. Am J Surg 164:176-177
120. Vanbockrijck M, Kloppel G (1992) Incidence and morphology of liver metastasis from extrahepatic malignancies to cirrhotic livers. Zentralbl Pathol 138:91-96
121. Qi K, Qiu H, Sun D et al (2004) Impact of cirrhosis on the development of experimental hepatic metastases by B16F1 melanoma cells in C57BL/6 mice. Hepatology 40: 1144-1150
122. Olaso E, Ikeda K, Eng FJ et al (2001) DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest 108:1369-1378
123. Badiola I, Vidal-Vanaclocha F, Olaso E (2010) Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. 15th ISCHS, Pasadena (CA)
124. Nomura K, Kadoya M, Ueda K et al (2007) Detection of hepatic metastases from colorectal carcinoma: comparison of histopathologic features of anatomically resected liver with results of preoperative imaging. J Clin Gastroenterol 41:789-795